AI assistant
Sending…
Ilirija d.d. — Interim / Quarterly Report 2017
Jul 28, 2017
2092_10-q_2017-07-28_9f6e166a-334a-48a2-944b-ddc06a35f40d.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
| Annex 1. | ||||||
|---|---|---|---|---|---|---|
| Reporting period | 01.01.2017. | 30.06.2017. | ||||
| Quarterly financial report TFI-POD | ||||||
| Tax number (MB): | 03311953 | |||||
| Company registration number (MBS): |
060032302 | |||||
| Personal identification number (OIB): |
05951496767 | |||||
| Issuing company: ILIRIJA d.d. | ||||||
| Postal code and place | 23210 | BIOGRAD NA MORU | ||||
| Street and house number: TINA UJEVIĆA 7 | ||||||
| E-mail address: [email protected] | ||||||
| Internet address www.ilirijabiograd.com | ||||||
| unicipality/city code and name | 22 | BIOGRAD NA MORU | ||||
| County code and name | 13 | ZADARSKA | Number of employees: | 404 | ||
| (period end) | ||||||
| Consolidated report: | NE | NKD code: | 55100 | |||
| Companies of the consolidation subject (according to IFRS): | Seat: | MB: | ||||
| Bookkeeping service: | ||||||
| Contact person: | STRPIĆ ZORKA | |||||
| (only surname and name) | ||||||
| Telephone: 023/383178 | Telefaks: | 023/384564 | ||||
| E-mail address: [email protected] | ||||||
| Family name and name: RAŽNJEVIĆ GORAN | ||||||
| (person authorized to represent the company) | ||||||
| Documents disclosed: 1. Financial statements (Balance Sheet, Income Statement, Cash Flow Statement, Statement of Changes in Equity and notes to financial statements); 2. Management Interim Report; 3. Declaration of the persons responsible for preparing the issuer's statements; |
||||||
| L.S. | (signature of the person authorized to represent the company) |
Balance Sheet
as of 30/06/2017
| Company: ILIRIJA d.d. BIOGRAD NA MORU | |||
|---|---|---|---|
| Position | AOP | Previous | Current |
| period | period | ||
| 1 | 2 | 3 | 4 |
| A) RECEIVABELS FOR SUBSCRIBED NOT PAID CAPITAL | 001 | ||
| B) NON-CURRENT ASSETS (003+010+020+029+033) | 002 | 314.174.173 | 409.904.850 |
| I. INTANGIBLE ASSETS (004 to 009) | 003 | 521.187 | 296.247 |
| 1. Expenditure for development | 004 | ||
| 2. Concessions, patents, licenses, trademarks, service marks, software and other rights | 005 | ||
| 3. Goodwill | 006 | ||
| 4. Advances for purchase of intangible assets | 007 | ||
| 5. Intangible assets in progress | 008 | ||
| 6. Other intangible assets | 009 | 521.187 | 296.247 |
| II. PROPERTY, PLANT AND EQUIPMENT (011 to 019) | 010 | 313.612.986 | 409.568.603 |
| 1. Land | 011 | 42.340.227 | 42.341.027 |
| 2. Buildings | 012 | 222.033.656 | 231.030.113 |
| 3. Plant and equipement | |||
| 013 | 39.122.311 | 41.845.865 | |
| 4. Tools, working inventory and transportation assets | 014 | ||
| 5. Biological assets | 015 | ||
| 6. Advances for purchase of tangible assets | 016 | 449.570 | 1.052.004 |
| 7. Tangible assets in progress | 017 | 9.667.222 | 13.918.761 |
| 8. Other tangible assets | 018 | ||
| 9. Investment in real-estate | 019 | 79.380.833 | |
| III. NON-CURRENT FINANCIAL ASSETS (021 to 028) | 020 | 40.000 | 40.000 |
| 1. Share in related parties | 021 | 40.000 | 40.000 |
| 2. Loans to related parties | 022 | ||
| 3. Participating interests (shares) | 023 | ||
| 4. Loans to companies with participating interest | 024 | ||
| 5. Investments in securities | 025 | ||
| 6. Loans, deposits, etc. | 026 | ||
| 7. Other non-current financial assets | 027 | ||
| 8. Equity-accounted investments | |||
| 028 | |||
| IV. RECEIVABLES (030 to 032) | 029 | 0 | 0 |
| 1. Receivables from related parties | 030 | ||
| 2. Receivables arising from sales on credit | 031 | ||
| 3. Other receivables | 032 | ||
| V. DEFERRED TAX ASSET | 033 | ||
| C) CURRENT ASSETS (035+043+050+058) | 034 | 20.247.910 | 22.996.967 |
| I. INVENTORIES (036 to 042) | 035 | 2.245.231 | 2.722.549 |
| 1. Raw materials and supplies | 036 | 2.245.231 | 2.722.549 |
| 2. Production in progress | 037 | ||
| 3. Finished products | 038 | ||
| 4. Merchandise | 039 | ||
| 5. Advances for inventories | 040 | ||
| 6. Long term assets held for sale | 041 | ||
| 7. Biological assets | 042 | ||
| II. RECEIVABLES (044 to 049) | 043 | 15.432.200 | 17.639.901 |
| 1. Receivables from related parties | 044 | ||
| 2. Receivables from end-customers | 045 | 14.499.557 | 15.421.009 |
| 3. Receivables from participating parties | 046 | ||
| 4. Receivables from employees and members of the company | 047 | 416.881 | 616.248 |
| 5. Receivables from government and other institutions | 048 | 515.762 | 1.602.644 |
| 6. Other receivables | 049 | ||
| III. CURRENT FINANCIAL ASSETS (051 to 057) | 050 | 2.399.511 | 2.389.547 |
| 1. Share in related parties | 051 | ||
| 2. Loans to related parties | 052 | ||
| 3. Participating interests (shares) | 053 | ||
| 4. Loans to companies with participating interest | |||
| 5. Investments in securities | 054 | ||
| 6. Loans, deposits, etc. | 055 | ||
| 056 | 2.399.511 | 2.389.547 | |
| 7. Other financial assets | 057 | ||
| IV. CASH AND CASH EQUIVALENTS | 058 | 170.968 | 244.970 |
| D) PREPAYMENTS AND ACCRUED INCOME | 059 | 122.449 | 2.506.337 |
| E) TOTAL ASSETS (001+002+034+059) | 060 | 334.544.532 | 435.408.154 |
| F) OFF BALANCE SHEET ITEMS | 061 |
| EQUITY AND LIABILITIES | |||
|---|---|---|---|
| A) ISSUED CAPITAL AND RESERVES (063+064+065+071+072+075+078) | 062 | 225.089.988 | 284.842.454 |
| I. SUBSCRIBED SHARE CAPITAL | 063 | 150.857.300 | 205.146.480 |
| II. CAPITAL RESERVES | 064 | 8.921.539 | 26.723.874 |
| III.RESERVES FROM PROFIT (066+067-068+069+070) | 065 | 23.561.457 | 23.435.964 |
| 1. Legal reserves | 066 | 9.477.986 | 9.477.986 |
| 2. Reserve for own shares | 067 | 6.975.716 | 6.975.716 |
| 3. Treasury shares and shares (deductible items) | 068 | 414.924 | 540.417 |
| 4. Statutory reserves | 069 | ||
| 5. Other reserves | 070 | 7.522.679 | 7.522.679 |
| IV. REVALUATION RESERVES | 071 | ||
| V. RETAINED EARNINGS OR LOSS CARRIED FORWARD (073-074) | 072 | 28.098.723 | 14.361.050 |
| 1. Retained earnings | 073 | 28.098.723 | 14.361.050 |
| 2. Loss carried forward | 074 | ||
| VI. NET PROFIT OR LOSS FOR THE PERIOD (076-077) | 075 | 13.650.969 | 15.175.086 |
| 1. Net profit for the period | 13.650.969 | 15.175.086 | |
| 2. Net loss for the period | 076 | ||
| VII. MINORITY INTEREST | 077 | ||
| 078 | |||
| B) PROVISIONS (080 to 082) | 079 | 0 | 0 |
| 1. Provisions for pensions, severance pay and similar liabilities | 080 | ||
| 2. Provisions for tax liabilities | 081 | ||
| 3. Other provisions | 082 | ||
| C) NON-CURRENT LIABILITIES (084 to 092) | 083 | 68.200.158 | 112.141.652 |
| 1. Liabilites to related parties | 084 | ||
| 2. Liabilities for loans, deposits, etc. | 085 | ||
| 3. Liabilities to banks and other financial institutions | 086 | 68.200.158 | 112.141.652 |
| 4. Liabilities for advances | 087 | ||
| 5. Trade payables | 088 | ||
| 6. Commitments on securities | 089 | ||
| 7. Liabilities to companies with participating interest | 090 | ||
| 8. Other non-current liabilities | 091 | ||
| 9. Deferred tax liabilities | 092 | ||
| D) CURRENT LIABILITIES (094 to 105) | 093 | 33.601.395 | 28.505.552 |
| 1. Liabilites to related parties | 094 | ||
| 2. Liabilities for loans, deposits, etc. | 095 | ||
| 3. Liabilities to banks and other financial institutions | 096 | 6.116.777 | 7.413.421 |
| 4. Liabilities for advances | 097 | ||
| 5. Trade payables | 098 | 14.756.586 | 9.994.764 |
| 6. Commitments on securities | 099 | ||
| 7. Liabilities to companies with participating interest | 100 | ||
| 8. Liabilities to emloyees | 101 | 1.910.701 | 2.183.311 |
| 9. Taxes, contributions and similar liabilities | 102 | 5.871.560 | 4.337.522 |
| 10. Liabilities arising from share in the result | 103 | ||
| 11. Liabilities arising from non-current assets held for sale | 104 | ||
| 12. Other current liabilities | 105 | 4.945.771 | 4.576.534 |
| E) ACCRUED EXPENSES AND DEFERRED INCOME | 106 | 7.652.991 | 9.918.496 |
| F) TOTAL EQUITY AND LIABILITIES (062+079+083+093+106) | 107 | 334.544.532 | 435.408.154 |
| G) OFF BALANCE SHEET ITEMS | 108 | ||
| ADDITION TO BALANCE SHEET (only for consolidated financial statements) | |||
| ISSUED CAPITAL AND RESERVES | |||
| 1. Attributable to majority owners | 109 | ||
| 2. Attributable to minority interest | 110 |
Income statement period 01/01/2017 to 30/06/2017
| Company: ILIRIJA d.d. BIOGRAD NA MORU | |||
|---|---|---|---|
| --------------------------------------- | -- | -- | -- |
| Position | AOP | Previous period | Current period | ||
|---|---|---|---|---|---|
| Cummulative | Quarter | Cummulative | Quarter | ||
| 1 | 2 | 3 | 4 | 5 | 6 |
| I. OPERATING INCOME (112 to 113) | 111 | 52.119.554 | 33.848.121 | 60.835.505 | 40.193.138 |
| 1. Sales revenues | 112 | 49.883.391 | 32.365.866 | 60.705.364 | 40.188.178 |
| 2. Other operating revenues | 113 | 2.236.163 | 1.482.255 | 130.141 | 4.960 |
| II. OPERATING COSTS (115+116+120+124+125+126+129+130) | 114 | 36.572.212 | 21.715.194 | 43.521.697 | 26.650.487 |
| 1. Change in inventories of work in progress | 115 | ||||
| 2. Material expenses (117 to 119) | 116 | 12.413.596 | 7.803.033 | 15.117.581 | 9.960.841 |
| a) Costs of raw materials | 117 | 6.369.692 | 4.696.505 | 8.782.119 | 6.709.575 |
| b) Cost of goods sold | 118 | ||||
| c) Other material expenses | 119 | 6.043.904 | 3.106.528 | 6.335.462 | 3.251.266 |
| 3. Employee benefits expenses (121 to 123) | 120 | 13.273.430 | 7.910.884 | 15.435.977 | 9.304.664 |
| a) Net salaries | 121 | 7.924.533 | 4.778.455 | 9.382.942 | 5.693.155 |
| b) Tax and contributions from salary expenses | 122 | 3.400.919 | 1.971.446 | 3.787.678 | 2.245.977 |
| c) Contributions on salary | 123 | 1.947.978 | 1.160.983 | 2.265.357 | 1.365.532 |
| 4. Depreciation and amortisation | 124 | 4.112.991 | 2.056.495 | 5.100.667 | 2.549.455 |
| 5. Other expenses | 125 | 6.286.039 | 3.628.554 | 7.867.472 | 4.835.527 |
| 6. Write down of assets (127+128) | 126 | 0 | 0 | 0 | 0 |
| a) non-current assets (except financial assets) | 127 | ||||
| b) current assets (except financial assets) | 128 | ||||
| 7. Provisions | 129 | ||||
| 8. Other operating costs | 130 | 486.156 | 316.228 | ||
| III. FINANCIAL INCOME (132 to 136) | 131 | 59.308 | 28.307 | 46.581 | 14.035 |
| 1. Interest, foreign exchange differences, dividens and similar income from related parties | 132 | ||||
| 2. Interest, foreign exchange differences, dividens and similar income from third parties | 133 | 59.308 | 28.307 | 46.581 | 14.035 |
| 3. Income from investments in associates and joint ventures | 134 | ||||
| 4. Unrealised gains (income) from financial assets | 135 | ||||
| 5. Other financial income | 136 | ||||
| IV. FINANCIAL EXPENSES (138 to 141) | 137 | 1.955.681 | 1.107.195 | 2.185.303 | 1.064.271 |
| 1. Interest, foreign exchange differences, dividends and similar income from related parties | 138 | ||||
| 2. Interest, foreign exchange differences, dividends and similar income from third parties | 139 | 1.955.681 | 1.107.195 | 2.185.303 | 1.064.271 |
| 3. Unrealised losses (expenses) from financial assets | 140 | ||||
| 4. Other financial expenses | 141 | ||||
| V. SHARE OF PROFIT FROM ASSOCIATED COMPANIES | 142 | ||||
| VI. SHARE OF LOSS FROM ASSOCIATED COMPANIES | 143 | ||||
| VII. EXTRAORDINARY - OTHER INCOME | 144 | ||||
| VIII. EXTRAORDINARY - OTHER EXPENSES | 145 | ||||
| IX. TOTAL INCOME (111+131+142+144) | 146 | 52.178.862 | 33.876.428 | 60.882.086 | 40.207.173 |
| X. TOTAL EXPENSES (114+137+143+145) | 147 | 38.527.893 | 22.822.389 | 45.707.000 | 27.714.758 |
| XI. PROFIT OR LOSS BEFORE TAXES (146-147) | 148 | 13.650.969 | 11.054.039 | 15.175.086 | 12.492.415 |
| 1. Profit before taxes (146-147) | 149 | 13.650.969 | 11.054.039 | 15.175.086 | 12.492.415 |
| 2. Loss before taxes (147-146) | 150 | 0 | 0 | 0 | 0 |
| XII. TAXATION | 151 | ||||
| XIII. PROFIT OR LOSS FOR THE PERIOD (148-151) | 152 | 13.650.969 | 11.054.039 | 15.175.086 | 12.492.415 |
| 1. Profit for the period (149-151) | 153 | 13.650.969 | 11.054.039 | 15.175.086 | 12.492.415 |
| 2. Loss for the period (151-148) | 154 | 0 | 0 | 0 | 0 |
| ADDITION TO PROFIT AND LOSS ACCOUNT (only for consolidated financial statements) | |||||
|---|---|---|---|---|---|
| XIV. PROFIT OR LOSS FOR THE PERIOD | |||||
| 1. Attributable to majority owners | 155 | ||||
| 2. Attributable to minority interest | 156 | ||||
| STATEMENT OF OTHER COMPREHENSIVE INCOME (only for IFRS adopters) | |||||
| I. PROFIT OR LOSS FOR THE PERIOD (=152) | 157 | ||||
| II. OTHER COMPREHENSIVE INCOME/LOSS BEFORE TAXES (159 to 165) | 158 | 0 | 0 | 0 | 0 |
| 1. Exchange differences from international settlement | 159 | ||||
| 2. Changes in revaluation reserves of long-term tangible and intangible assets | 160 | ||||
| 3. Profit or loss from re-evaluation of financial assets held for sale | 161 | ||||
| 4. Profit or loss from cash flow hedging | 162 | ||||
| 5. Profit or loss from hedging of foreign investments | 163 | ||||
| 6. Share of other comprehensive income/loss from associatied companies | 164 | ||||
| 7. Actuarial gains/losses from defined benefit plans | 165 | ||||
| III. TAXATION OF OTHER COMPREHENSIVE INCOME FOR THE PERIOD | 166 | ||||
| IV. NET OTHER COMPREHENSIVE INCOME FOR THE PERIOD (158 - 166) | 167 | 0 | 0 | 0 | 0 |
| V. COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD (157+167) | 168 | 0 | 0 | 0 | 0 |
| ADDITION TO STATEMENT OF OTHER COMPREHENSIVE INCOME (only for consolidated financial statements) | |||||
| VI. COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD | |||||
| 1. Attributable to majority owners | 169 | ||||
| 2. Attributable to minority interest | 170 |
Cash flow statement - indirect method period 01/01/2017 to 30/06/2017
| Company: ILIRIJA d.d. BIOGRAD NA MORU | |||
|---|---|---|---|
| Position | AOP | Previous period |
Current period |
| 1 | 2 | 3 | 4 |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| 1. Profit before tax | 001 | 13.650.696 | 15.175.086 |
| 2. Depreciation and amortisation | 002 | 377.880 | 987.676 |
| 3. Increase of current liabilities | 003 | ||
| 4. Decrease of current receivables | 004 | ||
| 5. Decrease of inventories | 005 | 540.843 | |
| 6. Other cash flow increases | 006 | 3.597.150 | |
| I. Total increase of cash flow from operating activities | 007 | 14.569.419 | 19.759.912 |
| 1. Decrease of current liabilities | 008 | 9.707.051 | 5.095.843 |
| 2. Increase of current receivables | 009 | 2.408.167 | 2.207.701 |
| 3. Increase of inventories | 010 | 477.318 | |
| 4. Other cash flow decreases | 011 | ||
| II. Total decrease of cash flow from operating activities | 012 | 12.115.218 | 7.780.862 |
| A1) NET INCREASE OF CASH FLOW FROM OPERATING ACTIVITIES | 013 | 2.454.474 | 11.979.050 |
| A2) NET DECREASE OF CASH FLOW FROM OPERATING ACTIVITIES | 014 | 0 | 0 |
| CASH FLOW FROM INVESTING ACTIVITIES | |||
| 1. Proceeds from sale of non-current assets | 015 | ||
| 2. Proceeds from sale of non-current financial assets | 016 | ||
| 3. Interest received | 017 | ||
| 4. Dividend received | 018 | ||
| 5. Other proceeds from investing activities | 019 | ||
| III. Total cash inflows from investing activities | 0 | 0 | |
| 1. Purchase of non-current assets | 020 | ||
| 2. Purchase of non-current financial assets | 021 | ||
| 3. Other cash outflows from investing activities | 022 | ||
| 023 | 9.239.243 | 14.983.546 | |
| IV. Total cash outflows from investing activities | 024 | 9.239.243 | 14.983.546 |
| B1) NET INCREASE OF CASH FLOW FROM INVESTING ACTIVITIES | 025 | 0 | 0 |
| B2) NET DECREASE OF CASH FLOW FROM INVESTING ACTIVITIES | 026 | 9.239.243 | 14.983.546 |
| CASH FLOW FROM FINANCING ACTIVITIES | |||
| 1. Proceeds from issue of equity securities and debt securities | 027 | ||
| 2. Proceeds from loans and borrowings | 028 | ||
| 3. Other proceeds from financing activities | 029 | 10.883.188 | 8.278.442 |
| V. Total cash inflows from financing activities | 030 | 10.883.188 | 8.278.442 |
| 1. Repayment of loans and bonds | 031 | ||
| 2. Dividends paid | 032 | ||
| 3. Repayment of finance lease | 033 | ||
| 4. Purchase of treasury shares | 034 | ||
| 5. Other cash outflows from financing activities | 035 | 4.265.327 | 5.199.944 |
| VI. Total cash outflows from financing activities | 036 | 4.265.327 | 5.199.944 |
| C1) NET INCREASE OF CASH FLOW FROM FINANCING ACTIVITIES | 037 | 6.617.861 | 3.078.498 |
| C2) NET DECREASE OF CASH FLOW FROM FINANCING ACTIVITIES | 038 | 0 | 0 |
| Total increases of cash flows (013-014+025-026+037-038) | 039 | 0 | 74.002 |
| Total decreases of cash flows (014-013+026-025+038-037) | 040 | 166.908 | 0 |
| Cash and cash equivalents at the beginning of period | 041 | 337.876 | 170.968 |
| Increase of cash and cash equivalents | 042 | ||
| Decrease of cash and cash equivalents | 043 | ||
| Cash and cash equivalents at the end of period | 044 | 170.968 | 244.970 |
| STATEMENT OF CHANGES IN EQUITY | |||
|---|---|---|---|
| period 30.6.2017 1.1.2017 to |
|||
| Position | AOP | Previous year |
Current year |
| 1 | 2 | 3 | 4 |
| 1. Subscribed share capital | 001 | 150.857.300 | 205.146.480 |
| 2. Capital reserves | 002 | 8.921.539 | 26.723.874 |
| 3. Reserves from profit | 003 | 23.561.457 | 23.435.964 |
| 4. Retained earnings or loss carried forward | 004 | 28.098.723 | 14.361.050 |
| 5. Net profit or loss for the period | 005 | 13.650.969 | 15.175.086 |
| 6. Revaluation of tangible assets | 006 | ||
| 7. Revaluation of intangible assets | 007 | ||
| 8. Revaluation of available for sale assets | 008 | ||
| 9. Other revaluation | 009 | ||
| 10. Total equity and reserves (AOP 001 to 009) | 010 | 225.089.988 | 284.842.454 |
| 11. Foreign exchenge differences from foreign investments | 011 | ||
| 12. Current and deferred taxes | 012 | ||
| 13. Cash flow hedge | 013 | ||
| 14. Change of accounting policies | 014 | ||
| 15. Correction of significant mistakes pf prior period | 015 | ||
| 16. Other changes | 016 | ||
| 17.Total increase or decrease of equity (AOP 011 to 016) | 017 | 13.650.969 | 15.175.086 |
| 17 a. Attributable to majority owners | 018 | ||
| 17 b. Attributable to minority interest | 019 |
More from Ilirija d.d.
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Report Publication Announcement
2026
Apr 29
Report Publication Announcement
2026
Apr 29
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 22
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 22
AGM Information
2026
Feb 26
Proxy Solicitation & Information Statement
2026
Feb 26